Download pdf
Role of Intermittent Energy Restriction (IER) in Weight Loss and Metabolic Parameters of Overweight/Obese Patients
- 1 Beijing Royal School, Beijing, 102209, China
* Author to whom correspondence should be addressed.
Abstract
Currently, obesity became a prevalence concern in terms of its scale and health-related impact among the global. Medical comprehensive intervention among dietary pattern and living manners are recommended by guidelines as foundation of obesity treatment. Identifying alternative dietary weight loss strategies become a common and safe choice for many obsess people’s medical consolers and clinical doctors. Many positive impacts of Intermittent Energy Restriction (IER) have been suggested by preliminary study, but it still lacks well-powered intervention studies. This passage objects at clarify the metabolic parameters, summarized evidence of preclinical studies of IER’s role in used as a weight loss strategy compared to other common strategies the guideline recommended, for instance, continuous energy restriction (CER), etc. Specifically, the randomized studies last 8-26 weeks performing in overweight and obsess adults. The result is compared in a paradigm of IER with CER, suggesting the outcome of weight loss and change in biomarkers of metabolic parameters. The evidence suggests that IER produce positive impact on weight loss and some positive but indirect effect on metabolic diseases.
Keywords
Metabolism, Weight Loss, Intermittent Fasting, Overweight, Obesity
[1]. W. H. Organization, "Obesity and overweight,” (2021).
[2]. R. Collier, "Intermittent fasting: the science of going without," Canadian Medical Association Journal, 185(9), E363-E364 (2013).
[3]. C. C. f. D. C. a. Prevention, "Report on nutrition and chronic diseases in China," Journal of Nutrition, 42(6), 1-10 (2020).
[4]. A. Simonnet, M. Chetboun, J. Poissy, et al., "High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation," Obesity (Silver Spring), 28(7), 1195-1199 (2020).
[5]. Y. Wang, L. Zhao, L. Gao, et al., "Health policy and public health implications of obesity in China," Lancet Diabetes Endocrinol, 9(7), 446-461 (2021).
[6]. J. F. Lison, G. Palomar, M. S. Mensorio, et al., "Impact of a Web-Based Exercise and Nutritional Education Intervention in Patients Who Are Obese With Hypertension: Randomized Wait-List Controlled Trial," J Med Internet Res, 22(4), e14196 (2020).
[7]. M. C. Turnin, O. Bourgeois, G. Cathelineau, et al., "Multicenter randomized evaluation of a nutritional education software in obese patients," Diabetes Metab, 27(2 Pt 1), 139-47 (2001).
[8]. S. Welton, R. Minty, T. O'Driscoll, et al., "Intermittent fasting and weight loss: Systematic review," Can Fam Physician, 66(2), 117-125 (2020).
[9]. M. P. Mattson, V. D. Longo,M. Harvie, "Impact of intermittent fasting on health and disease processes," Ageing Res Rev, 39, 46-58 (2017).
[10]. M. N. Harvie, M. Pegington, M. P. Mattson, et al., "The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women," Int J Obes (Lond), 35(5), 714-27 (2011).
[11]. R. Schubel, J. Nattenmuller, D. Sookthai, et al., "Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial," Am J Clin Nutr, 108(5), 933-945 (2018).
[12]. V. A. Catenacci, Z. Pan, D. Ostendorf, et al., "A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity," Obesity (Silver Spring), 24(9), 1874-83 (2016).
[13]. L. Schwingshackl, J. Zahringer, K. Nitschke, et al., "Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses," Crit Rev Food Sci Nutr, 61(8), 1293-1304 (2021).
[14]. H. Meng, L. Zhu, H. Kord-Varkaneh, et al., "Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis," Nutrition, 77, 110801 (2020).
[15]. B. Ahmed, R. Sultana,M. W. Greene, "Adipose tissue and insulin resistance in obese," Biomed Pharmacother, 137, 111315 (2021).
[16]. Y. Cho, N. Hong, K. W. Kim, et al., "The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis," J Clin Med, 8(10), 1645 (2019).
[17]. M. D. Jensen, D. H. Ryan, C. M. Apovian, et al., "2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society," J Am Coll Cardiol, 63(25 Pt B), 2985-3023 (2014).
[18]. S. D. Anton, S. A. Lee, W. T. Donahoo, et al., "The Effects of Time Restricted Feeding on Overweight, Older Adults: A Pilot Study," Nutrients, 11(7), 1500 (2019).
[19]. S. A. Lee, C. Sypniewski, B. A. Bensadon, et al., "Determinants of Adherence in Time-Restricted Feeding in Older Adults: Lessons from a Pilot Study," Nutrients, 12(3), 874 (2020).
[20]. M. L. G. Hiba Jebeile, Natalie B LIster, Marjan Mosalman Haghighi, Julian Ayer, Christopher T Cowell, Louise A Baur, Sarah P Garnett, "Intermittent Energy Restriction Is a Feasible, Effective, and Acceptable Intervention to Treat Adolescents with Obesity," Nutrients, 149(7), 1189-1197 (2019).
[21]. M. R. Michelle R Jospe, Rachel C Brown, Jullian J Haszard, Kim Meredith-Jones, Louise J Fanggupo, Hamish Osborne, Elizabeth A Fleming, Rachael W Taylor, "Intermittent fasting, Paleolithic, or Mediterranean diets in the real world: exploratory secondary analyses of a weight-loss trial that included choice of diet and exercise," The American Journal of Clinical Nutrition, 111(3), 503-514 (2020).
Cite this article
Wang,Y. (2023). Role of Intermittent Energy Restriction (IER) in Weight Loss and Metabolic Parameters of Overweight/Obese Patients. Theoretical and Natural Science,4,39-45.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part II
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).